Security
PetMed Express, Inc. Common Stock · PETS
PETSNASDAQCommon stockCurrentCIK 1040130Updated Nov 14, 2026
PETS price & chart
Loading TradingView…
NASDAQ:PETS on TradingView ↗About the company
Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PetMeds family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www. PetMeds.com and www. PetCareRx.com
In the news
PetMeds Appoints Andrew Parry as Chief Technology Officer ↗
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of PetMed Express, Inc. (NASDAQ: PETS) and Encourages Investors with Substantial Losses to Contact the Firm News provided by Edelson Lechtzin LLP Nov 28, 2025, 15:03 ET Share this article Share to X Share this article Share to X NEWTO ↗
Seeking Alpha
PetMeds outlines turnaround plan as customer acquisition cost falls 32% to $51 ↗
PetMed Express, Inc. (PETS) Q2 2027 Earnings Call Prepared Remarks Transcript ↗
PetMeds outlines $37M sale-leaseback while expecting the deal to close within about 120 days ↗
SEC disclosures
PETMED EXPRESS INC files 8-K: Material Event ↗
Recent filings
SCHEDULE 13G/A - filed by RENAISSANCE TECHNOLOGIES LLC regarding PETMED EXPRESS INC
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
S-8 filing
S-8 filing
Show 5 more recent filings
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure
Items 5.02, 7.01, 9.01
10-Q filing
SCHEDULE 13G/A filing
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 87,965,000Source | 144,795,000Source | 173,350,000Source | 100,301,000Source | 146,034,000Source | 63,762,000Source | 109,839,000Source | 152,714,000Source | 81,191,000Source | 148,700,000Source | 169,884,000Source | 167,478,000Source |
| Property, Plant and Equipment, NetUSD | 27,554,000Source | 28,425,000Source | 26,811,000Source | 28,338,000Source | 26,204,000Source | 25,213,000Source | 28,836,000Source | 26,109,000Source | 26,326,000Source | 28,859,000Source | 26,657,000Source | 26,178,000Source |
| GoodwillUSD | 0Source | 26,658,000Source | 26,657,000Source | 0Source | 26,658,000Source | — | 0Source | 26,658,000Source | 0Source | 26,658,000Source | 26,658,000Source | — |
| Intangible Assets, Net (Excluding Goodwill)USD | 5,978,000Source | 9,735,000Source | 11,692,000Source | 6,467,000Source | 10,224,000Source | 5,249,000Source | 6,956,000Source | 10,714,000Source | 5,489,000Source | 8,046,000Source | 11,203,000Source | 5,860,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 26,914,000Source | 50,101,000Source | 49,440,000Source | 36,098,000Source | 52,045,000Source | 13,079,000Source | 41,127,000Source | 45,992,000Source | 21,412,000Source | 54,720,000Source | 55,296,000Source | 104,086,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 1,559,000Source | 2,259,000Source | 1,930,000Source | 1,965,000Source | 1,620,000Source | 1,706,000Source | 1,605,000Source | 2,261,000Source | 1,908,000Source | 2,317,000Source | 3,283,000Source | 1,740,000Source |
| Inventory, NetUSD | 12,206,000Source | 11,795,000Source | — | 14,768,000Source | 13,092,000Source | 8,468,000Source | 18,361,000Source | — | 13,608,000Source | 16,205,000Source | — | — |
| Assets, CurrentUSD | 48,506,000Source | 68,383,000Source | 95,549,000Source | 59,455,000Source | 70,779,000Source | 27,605,000Source | 67,892,000Source | 77,624,000Source | 43,564,000Source | 78,871,000Source | 93,648,000Source | 130,431,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 7,569,000Source | 3,888,000Source | 8,804,000Source | 6,361,000Source | 3,655,000Source | 4,256,000Source | 6,500,000Source | 3,851,000Source | 6,378,000Source | 5,330,000Source | 6,325,000Source | 4,719,000Source |
| Operating Lease, Right-of-Use AssetUSD | 627,000Source | 1,077,000Source | 1,626,000Source | 741,000Source | 1,188,000Source | 395,000Source | 854,000Source | 1,297,000Source | 512,000Source | 966,000Source | 1,432,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 55,199,000Source | 48,611,000Source | 73,290,000Source | 57,237,000Source | 49,600,000Source | 40,773,000Source | 58,293,000Source | 59,183,000Source | 52,251,000Source | 63,566,000Source | 73,153,000Source | 57,512,000Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | — | 9,000Source | 9,000Source | — | 9,000Source | — | — | 9,000Source | — | — | 9,000Source | 9,000Source |
| Common Stock, Value, IssuedUSD | 21,000Source | 21,000Source | 21,000Source | 21,000Source | 21,000Source | 22,000Source | 21,000Source | 21,000Source | 21,000Source | 21,000Source | 21,000Source | 21,000Source |
| Additional Paid in CapitalUSD | 19,416,000Source | 17,967,000Source | 23,473,000Source | 19,161,000Source | 17,515,000Source | 19,840,000Source | 19,123,000Source | 16,942,000Source | 19,647,000Source | 18,560,000Source | 25,146,000Source | 18,277,000Source |
| Retained Earnings (Accumulated Deficit)USD | 13,320,000Source | 78,187,000Source | 76,557,000Source | 23,873,000Source | 78,889,000Source | 3,118,000Source | 32,393,000Source | 76,559,000Source | 9,263,000Source | 66,544,000Source | 71,555,000Source | 91,659,000Source |
| Stockholders' Equity Attributable to ParentUSD | 32,766,000Source | 96,184,000Source | 100,060,000Source | 43,064,000Source | 96,434,000Source | 22,989,000Source | 51,546,000Source | 93,531,000Source | 28,940,000Source | 85,134,000Source | 96,731,000Source | 109,966,000Source |
| Liabilities and EquityUSD | 87,965,000Source | 144,795,000Source | 173,350,000Source | 100,301,000Source | 146,034,000Source | 63,762,000Source | 109,839,000Source | 152,714,000Source | 81,191,000Source | 148,700,000Source | 169,884,000Source | 167,478,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 54,769,000Source | 47,959,000Source | 72,400,000Source | 56,683,000Source | 48,832,000Source | 40,598,000Source | 57,616,000Source | 58,300,000Source | 52,034,000Source | 62,768,000Source | 72,158,000Source | 57,512,000Source |
| Operating Lease, Liability, CurrentUSD | 485,000Source | 453,000Source | 752,000Source | 477,000Source | 446,000Source | 414,000Source | 469,000Source | 438,000Source | 493,000Source | 461,000Source | 459,000Source | — |
| Accounts Payable, CurrentUSD | 20,300,000Source | 10,945,000Source | 38,851,000Source | 19,119,000Source | 16,951,000Source | 12,298,000Source | 20,041,000Source | 24,467,000Source | 20,906,000Source | 23,564,000Source | 37,024,000Source | 25,208,000Source |
| Operating Lease, Liability, NoncurrentUSD | 167,000Source | 652,000Source | 890,000Source | 291,000Source | 768,000Source | 0Source | 414,000Source | 883,000Source | 42,000Source | 535,000Source | 995,000Source | — |
| Deferred Income Tax Liabilities, NetUSD | 263,000Source | — | — | 263,000Source | — | 175,000Source | 263,000Source | — | 175,000Source | 263,000Source | 4,585,000Source | 0Source |
| Other Liabilities, NoncurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Additional Financial Items | ||||||||||||
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 175,000Source | 263,000Source | — | — |
| Dividends Payable, CurrentUSD | — | — | — | — | — | — | — | — | 0Source | 26,000Source | 1,466,000Source | 1,262,000Source |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 2,399,000Source | 1,586,000Source | 2,278,000Source | 1,658,000Source | 2,148,000Source | 2,283,000Source | 9,387,000Source | 7,039,000Source | 7,056,000Source | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 300,000Source | 500,000Source | 200,000Source | 600,000Source | 198,000Source | 591,000Source | 1,365,000Source | -6,586,000Source | 6,869,000Source | 6,617,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -202,000Source | -718,000Source | -445,000Source | -601,000Source | 1,742,000Source | 41,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -5,140,000Source | 2,156,000Source | -471,000Source | -12,351,000Source | — | — |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | -8,608,000Source | -3,523,000Source | -2,658,000Source | -13,460,000Source | 6,102,000Source | -2,292,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | 0Source | -88,000Source | 5,249,000Source | 292,000Source | -1,630,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -7,687,000Source | -12,271,000Source | -28,394,000Source | 4,718,000Source | 4,317,000Source | 27,803,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 35,859,000Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -641,000Source | -1,292,000Source | -4,615,000Source | -5,113,000Source | -40,670,000Source | -10,260,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 641,000Source | 1,292,000Source | 4,615,000Source | 5,113,000Source | 4,511,000Source | 5,260,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | — | — | — | — | — | — | 5,000Source | 29,000Source | 278,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -5,000Source | -30,000Source | -299,000Source | -181,000Source | -12,437,000Source | -24,537,000Source |
| Payments of Ordinary Dividends, Common StockUSD | — | — | — | — | — | — | 0Source | 1,000Source | 21,000Source | 181,000Source | 12,437,000Source | 24,537,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -8,333,000Source | -13,593,000Source | -33,308,000Source | -576,000Source | -48,790,000Source | -6,994,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 26,914,000Source | 50,101,000Source | 36,098,000Source | 52,045,000Source | 13,079,000Source | 41,127,000Source | 21,412,000Source | 54,720,000Source | — | — |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | -120,000Source | -4,000Source | 52,000Source | 525,000Source | 130,000Source | 4,312,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 200,000Source | 500,000Source | 2,000,000Source | 2,000,000Source | 2,000,000Source | — |
| DepreciationUSD | — | — | — | — | — | — | — | — | — | 5,100,000Source | 5,100,000Source | 3,546,000Source |
| Dividends Payable, CurrentUSD | — | — | — | — | — | — | — | — | 0Source | 26,000Source | 1,466,000Source | 1,262,000Source |
| General and Administrative ExpenseUSD | — | — | 12,194,000Source | 10,786,000Source | 14,176,000Source | 10,492,000Source | 11,197,000Source | 12,948,000Source | 50,733,000Source | 38,647,000Source | 55,246,000Source | 41,714,000Source |
| GoodwillUSD | — | — | 0Source | 26,658,000Source | 0Source | 26,658,000Source | — | 0Source | 0Source | 26,658,000Source | 26,658,000Source | — |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | 26,700,000Source | — | — | 0Source | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | 600,000Source | 1,200,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 11,000Source | 465,000Source | 9,000Source | -1,401,000Source | 13,000Source | 9,000Source | -73,000Source | 5,684,000Source | 1,191,000Source | 2,305,000Source |
| Inventory Write-downUSD | — | — | 2,126,000Source | 0Source | — | — | — | — | 2,126,000Source | — | — | — |
| Investment Income, InterestUSD | — | — | 200,000Source | 500,000Source | — | — | 100,000Source | 300,000Source | — | — | — | 2,070,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -10,553,000Source | -707,000Source | -8,520,000Source | 2,326,000Source | -6,145,000Source | -34,152,000Source | -57,286,000Source | -6,271,000Source | -7,464,000Source | 5,140,000Source |
| Nonoperating Income (Expense)USD | — | — | -73,000Source | 208,000Source | -131,000Source | 371,000Source | 100,000Source | -11,000Source | 1,314,000Source | 943,000Source | 1,889,000Source | 1,394,000Source |
| Operating ExpensesUSD | — | — | 19,925,000Source | 16,581,000Source | 20,795,000Source | 18,219,000Source | 17,565,000Source | 48,535,000Source | 108,889,000Source | 70,667,000Source | 86,810,000Source | 64,684,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 148,000Source | 180,000Source | 195,000Source | 186,000Source | 438,000Source | 187,000Source | 803,000Source | 758,000Source | 1,378,000Source | 944,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | 281,064,000Source | 256,579,000Source |
| InterestExpenseNonoperating | — | — | —Source | —Source | — | — | —Source | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2027 | Q1 2026 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 40,660,000Source | 51,961,000Source | 44,364,000Source | 58,044,000Source | 41,015,000Source | 51,180,000Source | 179,021,000Source | 226,972,000Source | — | — |
| Cost of RevenueUSD | — | — | — | 35,830,000Source | 31,949,000Source | 39,271,000Source | 29,682,000Source | 36,777,000Source | — | 157,835,000Source | 202,416,000Source | 185,844,000Source |
| Operating Income (Loss)USD | — | — | -10,469,000Source | -450,000Source | -8,380,000Source | 554,000Source | -6,232,000Source | -34,132,000Source | -58,673,000Source | -1,530,000Source | -8,162,000Source | 6,051,000Source |
| Other Nonoperating Income (Expense)USD | — | — | 148,000Source | 180,000Source | 195,000Source | 186,000Source | 438,000Source | 187,000Source | 803,000Source | 758,000Source | 1,378,000Source | 944,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -10,542,000Source | -242,000Source | -8,511,000Source | 925,000Source | -6,132,000Source | -34,143,000Source | -57,359,000Source | -587,000Source | -6,273,000Source | 7,445,000Source |
| Income Tax Expense (Benefit)USD | — | — | 11,000Source | 465,000Source | 9,000Source | -1,401,000Source | 13,000Source | 9,000Source | -73,000Source | 5,684,000Source | 1,191,000Source | 2,305,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -10,553,000Source | -707,000Source | -8,520,000Source | 2,326,000Source | -6,145,000Source | -34,152,000Source | -57,286,000Source | -6,271,000Source | -7,464,000Source | 5,140,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.5Source | -0.03Source | -0.41Source | 0.11Source | -0.28Source | -1.65Source | -2.74Source | -0.3Source | -0.37Source | 0.25Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.5Source | -0.03Source | -0.41Source | 0.11Source | -0.28Source | -1.65Source | -2.74Source | -0.3Source | -0.37Source | 0.25Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 21,008,521Source | 20,634,651Source | 20,889,124Source | 20,597,807Source | 21,682,381Source | 20,755,416Source | 20,921,361Source | 20,596,022Source | 20,395,959Source | 20,275,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 21,008,521Source | 20,634,651Source | 20,889,124Source | 20,938,817Source | 21,682,381Source | 20,755,416Source | 20,921,361Source | 20,596,022Source | 20,395,959Source | 20,339,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 500,000Source | 500,000Source | 500,000Source | 500,000Source | 200,000Source | 500,000Source | 2,000,000Source | 2,000,000Source | 2,000,000Source | — |
| Common Stock, Dividends, Per Share, DeclaredUSD per share | — | — | — | 0Source | — | 0Source | — | — | 0Source | 0Source | 0.6Source | 1.2Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 14,000Source | 436,000Source | 898,000Source | 3,934,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | — | — | — | — | — | — | 7,400,000Source | — | — | — |
| General and Administrative ExpenseUSD | — | — | 12,194,000Source | 10,786,000Source | 14,176,000Source | 10,492,000Source | 11,197,000Source | 12,948,000Source | 50,733,000Source | 38,647,000Source | 55,246,000Source | 41,714,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | 26,700,000Source | — | — | 0Source | — |
| Gross ProfitUSD | — | — | 9,456,000Source | 16,131,000Source | 12,415,000Source | 18,773,000Source | 11,333,000Source | 14,403,000Source | 50,216,000Source | 69,137,000Source | 78,648,000Source | 70,735,000Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | -221,000Source | 28,000Source | -326,000Source | 185,000Source | -338,000Source | -198,000Source | 511,000Source | 185,000Source | — | — |
| Interest Revenue (Expense), NetUSD | — | — | — | — | — | — | — | — | — | — | 511,000Source | 450,000Source |
| Investment Income, InterestUSD | — | — | 200,000Source | 500,000Source | — | — | 100,000Source | 300,000Source | — | — | — | 2,070,000Source |
| Nonoperating Income (Expense)USD | — | — | -73,000Source | 208,000Source | -131,000Source | 371,000Source | 100,000Source | -11,000Source | 1,314,000Source | 943,000Source | 1,889,000Source | 1,394,000Source |
| Operating ExpensesUSD | — | — | 19,925,000Source | 16,581,000Source | 20,795,000Source | 18,219,000Source | 17,565,000Source | 48,535,000Source | 108,889,000Source | 70,667,000Source | 86,810,000Source | 64,684,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | — | — | — | — | — | — | — | 281,064,000Source | 256,579,000Source |
| Interest Expense (non-operating) | — | — | —Source | —Source | — | — | —Source | —Source | — | — | — | — |
Filing attachments
pets-q22027xex991.htm · 8-K · 2026-11-10
Exhibit 99.1 PetMeds® Announces Second Quarter Financial Results Delray Beach, Florida, November 10, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its second quarter ended September 30, 2026. Quarterly Highlights • For the second quarter ended September 30, 2026, net sales were $35.8 million compared to $44.4 million for the prior year period, a decrease of 19.4%, primarily driven by a decline in prescription m…
Read attachment ↗pets-q12027xex991.htm · 8-K · 2026-08-13
EX-99.1 2 pets-q12027xex991.htm EX-99.1 Document Exhibit 99.1 PetMeds® Announces First Quarter Financial Results Delray Beach, Florida, August 13, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its first quarter ended June 30, 2026. Quarterly Highlights • Net sales demonstrated sequential quarterly stabilization. For the first quarter ended June 30, 2026, net sales were $41.0 million compared to $51.2 milli…
Read attachment ↗ea029616301ex99-2.htm · SCHEDULE 13D/A · 2026-06-29
Exhibit 99.2 SilverCape Releases Revised Proposal to Acquire PetMed Express for $3.00 per Share in Cash Unaccountable Board Led by Chair & Interim CEO Leslie C.G. Campbell Continues to Preside Over Stunning Destruction of Stockholder Value Board’s Failure to Properly Consider Strategic Alternatives Amid Ongoing Erosion of Value Could Leave Stockholders with Nothing SilverCape Calls on Directors to Act as Independent Fiduciaries and Engage in Good Faith with its Proposal or Run a Bona Fide Pr…
Read attachment ↗pets-20260331xex107.htm · 10-K · 2026-06-02
Exhibit 10.7 PETMED EXPRESS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Dated: October 29, 2025) Non-employee members of the board of directors (the “Board”) of PetMed Express, Inc. (the “Company”) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this “Program”). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatically and without further action of the Board, to each memb…
Read attachment ↗pets-2026331xex991.htm · 8-K · 2026-06-02
EX-99.1 2 pets-2026331xex991.htm EX-99.1 Document Exhibit 99.1 PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results Delray Beach, Florida, June 2, 2026, PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ: PETS) today announced its financial results for its fourth quarter and fiscal year ended March 31, 2026. Fourth Quarter Fiscal 2026 Financial Highlights Compared to Prior Year Period • Net sales of $42.8 million compared to $50.8 million in the…
Read attachment ↗ex99-1.htm · SCHEDULE 13D · 2026-02-11
EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock, $0.001 par value per share (the “Shares”) of PetMed Express, Inc., a Florida corporation, dated as of February 11, 2026, is, and any amendments thereto signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. Dated: Februa…
Read attachment ↗